Warning: Undefined variable $zfal in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 525
Deprecated: str_replace(): Passing null to parameter #3 ($subject) of type array|string is deprecated in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 525
Warning: Undefined variable $sterm in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 530
 free
Warning: Undefined variable $sterm in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 531
 free
 free
Warning: file_get_contents(http://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&id=19895847&cmd=llinks): Failed to open stream: HTTP request failed! HTTP/1.1 429 Too Many Requests
in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 445
 
English Wikipedia
Nephropedia Template TP (
Twit Text
DeepDyve
Pubget Overpricing |  
lüll
The ABC of clinical and experimental adjuvants--a brief overview Brunner R; Jensen-Jarolim E; Pali-Scholl IImmunol Lett 2010[Jan]; 128 (1): 29-35Adjuvants are compounds that can increase and/or modulate the intrinsic immunogenicity of an antigen and elicit strong and long lasting immune responses. During the last 80 years many adjuvants have been used in experimental settings, but due to various shortcomings of most of them only aluminum compounds made it into regular clinical usage. However, during the last years promising candidates have arisen that may finally adjunct or displace aluminum substances as main adjuvant. This review summarizes information on adjuvants currently used in clinical as well as in experimental settings.|*Vaccines[MESH]|Adjuvants, Immunologic/pharmacology/*therapeutic use[MESH]|Aluminum Compounds/immunology/*therapeutic use[MESH]|Animals[MESH]|Bacterial Toxins/*immunology[MESH]|Flagellin/immunology[MESH]|Freund's Adjuvant/immunology[MESH]|Humans[MESH]|Lipid A/analogs & derivatives/immunology[MESH]|Nanoparticles[MESH]|Polysorbates[MESH]|Squalene/immunology[MESH]|Virosomes/*immunology[MESH] |
